Drug Insight: statin use in the elderly
O Christopher Raffel and Harvey D White*
Correspondence *Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92189, Auckland 1030, New Zealand
Email harveyw@adhb.govt.nz
More than 80% of the US elderly population dies from coronary heart disease, but the benefits of statin therapy are not realized. These drugs are frequently underprescribed to elderly patients because few relevant age-specific data are available. This Review draws together the findings from major studies and assesses the value of statin use in the elderly.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
